Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 13.4466 | 99 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 13.3713 | 99 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 13.382 | 99 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 13.1143 | 99 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 13.1165 | 99 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 13.5051 | 99 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 13.6088 | 100 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 13.0824 | 99 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 13.1755 | 99 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 13.4541 | 99 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 13.5346 | 100 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 13.3714 | 99 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 13.401 | 99 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 13.26 | 99 |